Implant Pharmacokinetic and Pharmacodynamic Study

NCT03634137 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Afamelanotide Group 1
DRUG: Afamelanotide Group 2

Sponsor

Clinuvel Pharmaceuticals Limited